Purpose: The study aimed to investigate the optimal isodose line (IDL) in linear accelerator-based stereotactic radiotherapy for single brain metastasis, using HyperArc. We compared the dosimetric parameters for target and normal brain tissue among six plans with different IDLs.
Methods: This study included 30 patients with single brain metastasis.
Objective: Dosimetric potential of knowledge-based RapidPlan planning model trained with HyperArc plans (Model-HA) for brain metastases has not been reported. We developed a Model-HA and compared its performance with that of clinical volumetric modulated arc therapy (VMAT) plans.
Methods: From 67 clinical stereotactic radiosurgery (SRS) HyperArc plans for brain metastases, 47 plans were used to build and train a Model-HA.
Background/aim: The aim of this retrospective study was to detect the frequency, reasons, and significant factors for not receiving immunotherapy after chemoradiotherapy in non-small cell lung cancer (NSCLC) patients.
Patients And Methods: Thirty-four patients with NSCLC received definitive chemoradiotherapy. The endpoint of this study was receiving durvalumab within 45 days after chemoradiotherapy for NSCLC.
Purpose: The aim of this study was to develop a deep learning (DL) method for generating virtual noncontrast (VNC) computed tomography (CT) images from contrast-enhanced (CE) CT images (VNC ) and to evaluate its performance in dose calculations for head and neck radiotherapy in comparison with VNC images derived from a dual-energy CT (DECT) scanner (VNC ).
Methods: This retrospective study included data for 61 patients who underwent head and neck radiotherapy. All planning CT images were obtained with a single-source DECT scanner (80 and 140 kVp) with rapid kVp switching.
Purpose: In stereotactic radiosurgery (SRS) with single-isocentric treatments for brain metastases, rotational setup errors may cause considerable dosimetric effects. We assessed the dosimetric effects on HyperArc plans for single and multiple metastases.
Methods: For 29 patients (1-8 brain metastases), HyperArc plans with a prescription dose of 20-24 Gy for a dose that covers 95% (D ) of the planning target volume (PTV) were retrospectively generated (Ref-plan).
We assessed the effect of collimator angle on the dosimetric parameters for targets and organs at risk (OARs) for collimator-optimized HA (CO-HA) and non-CO-HA (nCO-HA) plans. The nCO-HA and CO-HA plans were retrospectively generated for 26 patients (1 to 8 brain metastases). The dosimetric parameters for planning target volume (homogeneity index [HI]; conformity index [CI]; gradient index [GI]) and for OARs were compared.
View Article and Find Full Text PDF